To verify whether PHGDH and cMyc have synergistic effects in the clinical setting, we performed IHC with clinical liver cancer samples using antibodies against PHGDH, cMyc, and cMyc‐AcK148. The gene discussed is PHGDH; the disease is liver cancer.